Author/Creator: Wasserman, Matt - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Wasserman, Matt

1. Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine. (2nd January 2018)

Authors:: Wasserman, Matt; Sings, Heather L; Jones, Dylan; Pugh, Sarah; Moffatt, Margaret; Farkouh, Raymond
Journal:: Expert review of vaccines
Issue:: Volume 17:Number 1(2018)
Page Start:: 71
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Comment on Gomez et. al. "Response to article by Wasserman et. al. (2018) 'Modelling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico'". Issue 3 (4th March 2019)

Authors:: Wasserman, Matt; Palacios, Maria Gabriela; Grajales, Ana Gabriela; Wilson, Michele; McDade, Cheryl; Farkouh, Raymond
Journal:: Human vaccines & immunotherapeutics
Issue:: Volume 15:Issue 3(2019)
Page Start:: 572
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. Issue 4 (3rd April 2021)

Authors:: Perdrizet, Johnna; Santana, Carlos Felipe S.; Senna, Thais; Alexandre, Rodrigo Fernandes; Sini de Almeida, Rodrigo; Spinardi, Julia; Wasserman, Matt
Journal:: Human vaccines & immunotherapeutics
Issue:: Volume 17:Issue 4(2021)
Page Start:: 1162
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea. Issue 3 (4th March 2021)

Authors:: Kim, Hye-Young; Park, Seong-Beom; Kang, Eun-Sil; Lee, Sang-Min; Kim, Hyun-Jin; Wasserman, Matt
Journal:: Human vaccines & immunotherapeutics
Issue:: Volume 17:Issue 3(2021)
Page Start:: 909
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Estimating the Clinical and Economic Impact of Maintaining use of 13-valent Pneumococcal Conjugate Vaccine (PCV13) in Mexico. (4th October 2017)

Authors:: Wasserman, Matt; Wilson, Michele; McDade, Cheryl; Grajales, Ana Gabriela; Palacios, Maria Gabriela; Baez- Revueltas, Fabiola Berenice; Farkouh, Raymond
Journal:: Open forum infectious diseases
Issue:: Volume 4(2017)Supplement 1
Page Start:: S463
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Pneumococcal Vaccination Provides Substantial Value for Money for Canadians. (4th October 2017)

Authors:: Peloquin, Francois; Breton, Marie-Claude; Wasserman, Matt; Wilson, Michele; McDade, Cheryl; Farkouh, Raymond
Journal:: Open forum infectious diseases
Issue:: Volume 4(2017)Supplement 1
Page Start:: S464
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Reply letter to "response to article by Johnna Perdrizet et al." by Gomez and colleagues. Issue 1 (31st December 2022)

Authors:: Perdrizet, Johnna; Santana, Carlos Felipe S.; Senna, Thais; Alexandre, Rodrigo Fernandes; Sini de Almeida, Rodrigo; Spinardi, Julia; Wasserman, Matt
Journal:: Human vaccines & immunotherapeutics
Issue:: Volume 18:Issue 1(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Community-acquired pneumonia in infants: Not simply an acute event with complete recovery. (January 2022)

Authors:: Lapidot, Rotem; Vietri, Jeffrey; Shaff, Melody; Averin, Ahuva; Lonshteyn, Alex; Weycker, Derek; Wasserman, Matt; Farkouh, Ray; Pelton, Stephen I.
Journal:: Respiratory medicine
Issue:: Volume 191(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt. Issue 6 (30th November 2022)

Authors:: Sevilla, JP; Burnes, Daria; El Saie, Rehab Zakaria; Haridy, Hammam; Wasserman, Matt; Pugh, Sarah; Perdrizet, Johnna; Bloom, David
Journal:: Human vaccines & immunotherapeutics
Issue:: Volume 18:Issue 6(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. A systematic literature review of economic evaluations of pneumococcal conjugate vaccines in east and southeast Asia (2006-2019). (3rd July 2022)

Authors:: Wang, Bruce Cm; Chaiyakunapruk, Nathorn; Zhu, Shuiqing; Babigumira, Joseph B.; Furnback, Wesley; Chitale, Ramaa; Gamil, Amgad; Zhao, Kun; Wasserman, Matt
Journal:: Expert review of vaccines
Issue:: Volume 21:Number 7(2022)
Page Start:: 885
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗